An Efficacy and Safety Study of Carisbamate in the Treatment of Nerve Pain in Diabetics
Status:
Completed
Trial end date:
2010-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the safety, tolerability, and efficacy of
carisbamate (800 and 1200 mg/day) in patients with diabetic neuropathic pain.